[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fXCzsKYsT5MdSmRo1bVvuKm38Ag_FbjE1OsUps2S1RVg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":58,"rows":65},"Hartford Hospital",[4],103,false,13,3,10081,11,53,[14,17,20,22,24,27,29,31],{"name":15,"count":16},"Obesity",7,{"name":18,"count":19},"Pelvic Organ Prolapse",5,{"name":21,"count":19},"Coronary Artery Disease",{"name":23,"count":19},"Diabetes",{"name":25,"count":26},"Wound Infection",4,{"name":28,"count":26},"Healthy Volunteers",{"name":30,"count":9},"Myocardial Ischemia",{"name":32,"count":9},"Generalized Anxiety Disorder",[34,39,44,49,54],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05224089","Bilateral TAP and RS Blocks Using Liposomal Bupivacaine\u002FBupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy","2025-11","Liposomal Bupivicaine\u002FBupivacaine Admixture",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06068764","Etomidate Versus Propofol in CABG Surgery","2025-12","Etomidate",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT05972018","Liposomal Bupivacaine\u002FBupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters","2026-10-30","Liposomal bupivacaine",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT04855526","THC + CBD and Memory Study","2026-12-30","High THC\u002FNo CBD Marihuana",{"nctId":55,"briefTitle":56,"date":52,"intervention":57},"NCT05996133","Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery","Bupivacaine Hcl 0.25% Inj",[59,60,61,62,63,64],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[66,109,132,150,168,186,208,230,248,274,292,310,347,383,408,426,450,477,504,527,554,572,602,620,648,674,692,715,754,772,790,808,826,844,862,880,898,916,934,959,983,1007,1033,1059,1083,1109,1135,1153,1176,1203,1221,1239,1263,1287,1310,1334,1357,1381,1405,1429,1465,1490,1514,1539,1557,1583,1601,1626,1652,1677,1701,1726],{"intervention":48,"totalTrials":67,"cells":68},2,{"EARLY_PHASE1":69,"PHASE1":72,"PHASE2":74,"PHASE3":76,"PHASE4":78,"NA":107},{"trials":70,"activeCount":71},[],0,{"trials":73,"activeCount":71},[],{"trials":75,"activeCount":71},[],{"trials":77,"activeCount":71},[],{"trials":79,"activeCount":106,"soonestReadout":47},[80,93],{"nctId":81,"briefTitle":82,"status":83,"phases":84,"primaryCompletion":85,"completion":42,"start":86,"enrollment":87,"conditions":88,"interventions":91},"NCT06107660","Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion","UNKNOWN",[63],"2025-06","2023-12",100,[89,90],"Spine Fusion","Anesthesia, Local",[48,92],"Bupivacaine",{"nctId":45,"briefTitle":46,"status":94,"phases":95,"primaryCompletion":47,"completion":52,"start":96,"enrollment":97,"conditions":98,"interventions":103},"RECRUITING",[63],"2023-10-18",14,[99,100,101,102],"Aortic Aneurysm, Abdominal","Abdominal Aortic Occlusion","Aortoiliac Occlusive Disease","Aortic Diseases",[48,104,105],"Ropivacaine","Bupivacain",1,{"trials":108,"activeCount":71},[],{"intervention":38,"totalTrials":106,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":117,"PHASE4":119,"NA":130},{"trials":112,"activeCount":71},[],{"trials":114,"activeCount":71},[],{"trials":116,"activeCount":71},[],{"trials":118,"activeCount":71},[],{"trials":120,"activeCount":106,"soonestReadout":37},[121],{"nctId":35,"briefTitle":36,"status":94,"phases":122,"primaryCompletion":37,"completion":123,"start":124,"enrollment":125,"conditions":126,"interventions":128},[63],"2026-02","2022-04-27",114,[127],"Bowel Disease",[38,129],"Bupivacaine HCL",{"trials":131,"activeCount":71},[],{"intervention":129,"totalTrials":106,"cells":133},{"EARLY_PHASE1":134,"PHASE1":136,"PHASE2":138,"PHASE3":140,"PHASE4":142,"NA":148},{"trials":135,"activeCount":71},[],{"trials":137,"activeCount":71},[],{"trials":139,"activeCount":71},[],{"trials":141,"activeCount":71},[],{"trials":143,"activeCount":106,"soonestReadout":37},[144],{"nctId":35,"briefTitle":36,"status":94,"phases":145,"primaryCompletion":37,"completion":123,"start":124,"enrollment":125,"conditions":146,"interventions":147},[63],[127],[38,129],{"trials":149,"activeCount":71},[],{"intervention":104,"totalTrials":106,"cells":151},{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":158,"PHASE4":160,"NA":166},{"trials":153,"activeCount":71},[],{"trials":155,"activeCount":71},[],{"trials":157,"activeCount":71},[],{"trials":159,"activeCount":71},[],{"trials":161,"activeCount":106,"soonestReadout":47},[162],{"nctId":45,"briefTitle":46,"status":94,"phases":163,"primaryCompletion":47,"completion":52,"start":96,"enrollment":97,"conditions":164,"interventions":165},[63],[99,100,101,102],[48,104,105],{"trials":167,"activeCount":71},[],{"intervention":105,"totalTrials":106,"cells":169},{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":176,"PHASE4":178,"NA":184},{"trials":171,"activeCount":71},[],{"trials":173,"activeCount":71},[],{"trials":175,"activeCount":71},[],{"trials":177,"activeCount":71},[],{"trials":179,"activeCount":106,"soonestReadout":47},[180],{"nctId":45,"briefTitle":46,"status":94,"phases":181,"primaryCompletion":47,"completion":52,"start":96,"enrollment":97,"conditions":182,"interventions":183},[63],[99,100,101,102],[48,104,105],{"trials":185,"activeCount":71},[],{"intervention":57,"totalTrials":106,"cells":187},{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":194,"PHASE4":196,"NA":206},{"trials":189,"activeCount":71},[],{"trials":191,"activeCount":71},[],{"trials":193,"activeCount":71},[],{"trials":195,"activeCount":71},[],{"trials":197,"activeCount":106,"soonestReadout":52},[198],{"nctId":55,"briefTitle":56,"status":94,"phases":199,"primaryCompletion":52,"completion":200,"start":201,"enrollment":202,"conditions":203,"interventions":205},[63],"2027-06-30","2023-12-12",38,[204],"Cervical Spine Fusion",[57],{"trials":207,"activeCount":71},[],{"intervention":43,"totalTrials":106,"cells":209},{"EARLY_PHASE1":210,"PHASE1":212,"PHASE2":214,"PHASE3":216,"PHASE4":218,"NA":228},{"trials":211,"activeCount":71},[],{"trials":213,"activeCount":71},[],{"trials":215,"activeCount":71},[],{"trials":217,"activeCount":71},[],{"trials":219,"activeCount":106,"soonestReadout":42},[220],{"nctId":40,"briefTitle":41,"status":94,"phases":221,"primaryCompletion":42,"completion":222,"start":223,"enrollment":224,"conditions":225,"interventions":226},[63],"2026-08","2023-12-05",300,[21],[43,227],"Propofol",{"trials":229,"activeCount":71},[],{"intervention":227,"totalTrials":106,"cells":231},{"EARLY_PHASE1":232,"PHASE1":234,"PHASE2":236,"PHASE3":238,"PHASE4":240,"NA":246},{"trials":233,"activeCount":71},[],{"trials":235,"activeCount":71},[],{"trials":237,"activeCount":71},[],{"trials":239,"activeCount":71},[],{"trials":241,"activeCount":106,"soonestReadout":42},[242],{"nctId":40,"briefTitle":41,"status":94,"phases":243,"primaryCompletion":42,"completion":222,"start":223,"enrollment":224,"conditions":244,"interventions":245},[63],[21],[43,227],{"trials":247,"activeCount":71},[],{"intervention":53,"totalTrials":106,"cells":249},{"EARLY_PHASE1":250,"PHASE1":264,"PHASE2":266,"PHASE3":268,"PHASE4":270,"NA":272},{"trials":251,"activeCount":106,"soonestReadout":52},[252],{"nctId":50,"briefTitle":51,"status":253,"phases":254,"primaryCompletion":52,"completion":52,"start":255,"enrollment":256,"conditions":257,"interventions":261},"NOT_YET_RECRUITING",[59],"2025-12-01",9,[258,259,260],"Marijuana Use","Cannabis Use","Cannabis Intoxication",[53,262,263],"High THC\u002FHigh CBD Marihuana","No THC\u002FNo CBD Marihuana",{"trials":265,"activeCount":71},[],{"trials":267,"activeCount":71},[],{"trials":269,"activeCount":71},[],{"trials":271,"activeCount":71},[],{"trials":273,"activeCount":71},[],{"intervention":262,"totalTrials":106,"cells":275},{"EARLY_PHASE1":276,"PHASE1":282,"PHASE2":284,"PHASE3":286,"PHASE4":288,"NA":290},{"trials":277,"activeCount":106,"soonestReadout":52},[278],{"nctId":50,"briefTitle":51,"status":253,"phases":279,"primaryCompletion":52,"completion":52,"start":255,"enrollment":256,"conditions":280,"interventions":281},[59],[258,259,260],[53,262,263],{"trials":283,"activeCount":71},[],{"trials":285,"activeCount":71},[],{"trials":287,"activeCount":71},[],{"trials":289,"activeCount":71},[],{"trials":291,"activeCount":71},[],{"intervention":263,"totalTrials":106,"cells":293},{"EARLY_PHASE1":294,"PHASE1":300,"PHASE2":302,"PHASE3":304,"PHASE4":306,"NA":308},{"trials":295,"activeCount":106,"soonestReadout":52},[296],{"nctId":50,"briefTitle":51,"status":253,"phases":297,"primaryCompletion":52,"completion":52,"start":255,"enrollment":256,"conditions":298,"interventions":299},[59],[258,259,260],[53,262,263],{"trials":301,"activeCount":71},[],{"trials":303,"activeCount":71},[],{"trials":305,"activeCount":71},[],{"trials":307,"activeCount":71},[],{"trials":309,"activeCount":71},[],{"intervention":311,"totalTrials":67,"cells":312},"Cefiderocol",{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":327,"PHASE3":329,"PHASE4":331,"NA":345},{"trials":314,"activeCount":71},[],{"trials":316,"activeCount":71},[317],{"nctId":318,"briefTitle":319,"status":320,"phases":321,"primaryCompletion":322,"completion":322,"start":323,"enrollment":97,"conditions":324,"interventions":326},"NCT05373615","Cefiderocol Plasma Concentrations in Patients Receiving Renal Replacement Therapy","COMPLETED",[60],"2024-11-20","2022-07-25",[325],"Pharmacokinetics",[311],{"trials":328,"activeCount":71},[],{"trials":330,"activeCount":71},[],{"trials":332,"activeCount":71},[333],{"nctId":334,"briefTitle":335,"status":320,"phases":336,"primaryCompletion":337,"completion":338,"start":339,"enrollment":340,"conditions":341,"interventions":344},"NCT05314764","Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis",[63],"2024-06-01","2024-12-11","2022-06-01",10,[342,343],"Cystic Fibrosis","Pneumonia, Bacterial",[311],{"trials":346,"activeCount":71},[],{"intervention":348,"totalTrials":67,"cells":349},"magnesium L-lactate",{"EARLY_PHASE1":350,"PHASE1":352,"PHASE2":354,"PHASE3":356,"PHASE4":358,"NA":381},{"trials":351,"activeCount":71},[],{"trials":353,"activeCount":71},[],{"trials":355,"activeCount":71},[],{"trials":357,"activeCount":71},[],{"trials":359,"activeCount":71},[360,371],{"nctId":361,"briefTitle":362,"status":320,"phases":363,"primaryCompletion":364,"completion":364,"start":365,"enrollment":366,"conditions":367,"interventions":370},"NCT00282659","The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control",[63],"2008-06","2006-01",240,[21,368,369,23],"Hypertension","Dyslipidemia",[348],{"nctId":372,"briefTitle":373,"status":83,"phases":374,"completion":364,"start":365,"enrollment":366,"conditions":375,"interventions":379},"NCT00282620","Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.",[63],[376,377,378],"Arrhythmia","Quality of Life","Hypomagnesemia",[380],"Magnesium L-lactate",{"trials":382,"activeCount":71},[],{"intervention":384,"totalTrials":106,"cells":385},"Solifenacin",{"EARLY_PHASE1":386,"PHASE1":388,"PHASE2":390,"PHASE3":392,"PHASE4":394,"NA":406},{"trials":387,"activeCount":71},[],{"trials":389,"activeCount":71},[],{"trials":391,"activeCount":71},[],{"trials":393,"activeCount":71},[],{"trials":395,"activeCount":71},[396],{"nctId":397,"briefTitle":398,"status":399,"phases":400,"primaryCompletion":401,"completion":401,"start":402,"enrollment":403,"conditions":404,"interventions":405},"NCT01092624","Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse","TERMINATED",[63],"2011-10","2010-03",94,[18],[384],{"trials":407,"activeCount":71},[],{"intervention":92,"totalTrials":106,"cells":409},{"EARLY_PHASE1":410,"PHASE1":412,"PHASE2":414,"PHASE3":416,"PHASE4":418,"NA":424},{"trials":411,"activeCount":71},[],{"trials":413,"activeCount":71},[],{"trials":415,"activeCount":71},[],{"trials":417,"activeCount":71},[],{"trials":419,"activeCount":71},[420],{"nctId":81,"briefTitle":82,"status":83,"phases":421,"primaryCompletion":85,"completion":42,"start":86,"enrollment":87,"conditions":422,"interventions":423},[63],[89,90],[48,92],{"trials":425,"activeCount":71},[],{"intervention":427,"totalTrials":106,"cells":428},"Administration of weight loss drug",{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":435,"PHASE4":437,"NA":448},{"trials":430,"activeCount":71},[],{"trials":432,"activeCount":71},[],{"trials":434,"activeCount":71},[],{"trials":436,"activeCount":71},[],{"trials":438,"activeCount":71},[439],{"nctId":440,"briefTitle":441,"status":399,"phases":442,"primaryCompletion":443,"completion":443,"start":444,"enrollment":445,"conditions":446,"interventions":447},"NCT03603080","Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy",[63],"2022-09-01","2019-03-01",12,[15],[427],{"trials":449,"activeCount":71},[],{"intervention":451,"totalTrials":106,"cells":452},"Ascorbic acid",{"EARLY_PHASE1":453,"PHASE1":455,"PHASE2":457,"PHASE3":459,"PHASE4":461,"NA":475},{"trials":454,"activeCount":71},[],{"trials":456,"activeCount":71},[],{"trials":458,"activeCount":71},[],{"trials":460,"activeCount":71},[],{"trials":462,"activeCount":71},[463],{"nctId":464,"briefTitle":465,"status":320,"phases":466,"primaryCompletion":467,"completion":468,"start":469,"enrollment":470,"conditions":471,"interventions":474},"NCT00519337","Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation",[63],"2009-10","2011-04","2008-10",25,[472,473],"Cardiac Surgery","Inflammation",[451],{"trials":476,"activeCount":71},[],{"intervention":478,"totalTrials":106,"cells":479},"Simvastatin 20 mg",{"EARLY_PHASE1":480,"PHASE1":482,"PHASE2":484,"PHASE3":486,"PHASE4":488,"NA":502},{"trials":481,"activeCount":71},[],{"trials":483,"activeCount":71},[],{"trials":485,"activeCount":71},[],{"trials":487,"activeCount":71},[],{"trials":489,"activeCount":71},[490],{"nctId":491,"briefTitle":492,"status":83,"phases":493,"primaryCompletion":494,"completion":495,"start":496,"enrollment":497,"conditions":498,"interventions":501},"NCT03653663","NIRS to Diagnose SAMS",[63],"2020-02-29","2020-07-30","2018-01-01",40,[499,500],"Statin Adverse Reaction","Skeletal Myopathy",[478],{"trials":503,"activeCount":71},[],{"intervention":505,"totalTrials":106,"cells":506},"Imipenem\u002FCilastatin\u002FRelebactam",{"EARLY_PHASE1":507,"PHASE1":509,"PHASE2":511,"PHASE3":513,"PHASE4":515,"NA":525},{"trials":508,"activeCount":71},[],{"trials":510,"activeCount":71},[],{"trials":512,"activeCount":71},[],{"trials":514,"activeCount":71},[],{"trials":516,"activeCount":71},[517],{"nctId":518,"briefTitle":519,"status":399,"phases":520,"primaryCompletion":521,"completion":338,"start":522,"enrollment":26,"conditions":523,"interventions":524},"NCT05561764","Imipenem\u002FCilastatin\u002FRelebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis",[63],"2024-10-14","2023-01-03",[342,343],[505],{"trials":526,"activeCount":71},[],{"intervention":528,"totalTrials":106,"cells":529},"Sildenafil therapy plus post-NSRRP HBO2T",{"EARLY_PHASE1":530,"PHASE1":532,"PHASE2":534,"PHASE3":536,"PHASE4":538,"NA":552},{"trials":531,"activeCount":71},[],{"trials":533,"activeCount":71},[],{"trials":535,"activeCount":71},[],{"trials":537,"activeCount":71},[],{"trials":539,"activeCount":71},[540],{"nctId":541,"briefTitle":542,"status":83,"phases":543,"primaryCompletion":544,"completion":545,"start":546,"enrollment":87,"conditions":547,"interventions":550},"NCT00906269","Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer",[63],"2020-07","2021-01","2009-07",[548,549],"Impotence","Prostatic Neoplasms",[528,551],"Sildenafil therapy plus sham post-NSRRP HBO2T",{"trials":553,"activeCount":71},[],{"intervention":551,"totalTrials":106,"cells":555},{"EARLY_PHASE1":556,"PHASE1":558,"PHASE2":560,"PHASE3":562,"PHASE4":564,"NA":570},{"trials":557,"activeCount":71},[],{"trials":559,"activeCount":71},[],{"trials":561,"activeCount":71},[],{"trials":563,"activeCount":71},[],{"trials":565,"activeCount":71},[566],{"nctId":541,"briefTitle":542,"status":83,"phases":567,"primaryCompletion":544,"completion":545,"start":546,"enrollment":87,"conditions":568,"interventions":569},[63],[548,549],[528,551],{"trials":571,"activeCount":71},[],{"intervention":573,"totalTrials":106,"cells":574},"Liposomal Bupivicaine 1.3%",{"EARLY_PHASE1":575,"PHASE1":577,"PHASE2":579,"PHASE3":581,"PHASE4":583,"NA":600},{"trials":576,"activeCount":71},[],{"trials":578,"activeCount":71},[],{"trials":580,"activeCount":71},[],{"trials":582,"activeCount":71},[],{"trials":584,"activeCount":71},[585],{"nctId":586,"briefTitle":587,"status":320,"phases":588,"primaryCompletion":589,"completion":590,"start":591,"enrollment":592,"conditions":593,"interventions":598},"NCT03887650","LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs",[63],"2022-01-11","2022-03-08","2019-03-11",90,[594,595,596,597],"Post-operative Pain","Total Shoulder Arthroplasty","Osteoarthritis of the Shoulder","Pain Management",[573,599],"Bupivacaine 0.5%",{"trials":601,"activeCount":71},[],{"intervention":599,"totalTrials":106,"cells":603},{"EARLY_PHASE1":604,"PHASE1":606,"PHASE2":608,"PHASE3":610,"PHASE4":612,"NA":618},{"trials":605,"activeCount":71},[],{"trials":607,"activeCount":71},[],{"trials":609,"activeCount":71},[],{"trials":611,"activeCount":71},[],{"trials":613,"activeCount":71},[614],{"nctId":586,"briefTitle":587,"status":320,"phases":615,"primaryCompletion":589,"completion":590,"start":591,"enrollment":592,"conditions":616,"interventions":617},[63],[594,595,596,597],[573,599],{"trials":619,"activeCount":71},[],{"intervention":621,"totalTrials":106,"cells":622},"Etoricoxib",{"EARLY_PHASE1":623,"PHASE1":625,"PHASE2":627,"PHASE3":629,"PHASE4":631,"NA":646},{"trials":624,"activeCount":71},[],{"trials":626,"activeCount":71},[],{"trials":628,"activeCount":71},[],{"trials":630,"activeCount":71},[],{"trials":632,"activeCount":71},[633],{"nctId":634,"briefTitle":635,"status":320,"phases":636,"primaryCompletion":637,"completion":637,"start":638,"enrollment":639,"conditions":640,"interventions":645},"NCT01148303","Trial of Etoricoxib (Arcoxia) Taken Prophylactically to Prevent Ramadan Headache",[63],"2010-08","2010-07",220,[641,642,643,644],"Headache","Fasting","Fasting Headache","Ramadan Headache",[621,621],{"trials":647,"activeCount":71},[],{"intervention":649,"totalTrials":106,"cells":650},"Vancomycin",{"EARLY_PHASE1":651,"PHASE1":653,"PHASE2":655,"PHASE3":657,"PHASE4":659,"NA":672},{"trials":652,"activeCount":71},[],{"trials":654,"activeCount":71},[],{"trials":656,"activeCount":71},[],{"trials":658,"activeCount":71},[],{"trials":660,"activeCount":71},[661],{"nctId":662,"briefTitle":663,"status":320,"phases":664,"primaryCompletion":665,"completion":665,"start":666,"enrollment":667,"conditions":668,"interventions":670},"NCT01818141","Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin",[63],"2014-12-15","2012-10-17",34,[669],"Clostridium Difficile Infection",[649,671],"Fidaxomicin",{"trials":673,"activeCount":71},[],{"intervention":671,"totalTrials":106,"cells":675},{"EARLY_PHASE1":676,"PHASE1":678,"PHASE2":680,"PHASE3":682,"PHASE4":684,"NA":690},{"trials":677,"activeCount":71},[],{"trials":679,"activeCount":71},[],{"trials":681,"activeCount":71},[],{"trials":683,"activeCount":71},[],{"trials":685,"activeCount":71},[686],{"nctId":662,"briefTitle":663,"status":320,"phases":687,"primaryCompletion":665,"completion":665,"start":666,"enrollment":667,"conditions":688,"interventions":689},[63],[669],[649,671],{"trials":691,"activeCount":71},[],{"intervention":693,"totalTrials":106,"cells":694},"ertapenem",{"EARLY_PHASE1":695,"PHASE1":697,"PHASE2":699,"PHASE3":701,"PHASE4":703,"NA":713},{"trials":696,"activeCount":71},[],{"trials":698,"activeCount":71},[],{"trials":700,"activeCount":71},[],{"trials":702,"activeCount":71},[],{"trials":704,"activeCount":71},[705],{"nctId":706,"briefTitle":707,"status":320,"phases":708,"primaryCompletion":709,"completion":709,"start":637,"enrollment":445,"conditions":710,"interventions":712},"NCT01148771","Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion",[63],"2010-10",[711],"Healthy",[693,693],{"trials":714,"activeCount":71},[],{"intervention":716,"totalTrials":106,"cells":717},"Celebrex",{"EARLY_PHASE1":718,"PHASE1":720,"PHASE2":722,"PHASE3":724,"PHASE4":726,"NA":752},{"trials":719,"activeCount":71},[],{"trials":721,"activeCount":71},[],{"trials":723,"activeCount":71},[],{"trials":725,"activeCount":71},[],{"trials":727,"activeCount":71},[728],{"nctId":729,"briefTitle":730,"status":320,"phases":731,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":736,"interventions":741},"NCT02110719","Decreasing Narcotics in Advanced Pelvic Surgery",[63],"2015-07","2016-06","2014-03",138,[737,738,739,740],"Narcotic Use","Pain","Constipation","Nausea",[716,742,743,744,745,746,747,748,749,750,751],"Gabapentin","IV acetaminophen","oral acetaminophen","oral ibuprofen","percocet","vicodin","Oxycodone","dilaudid","Dexamethasone","zofran",{"trials":753,"activeCount":71},[],{"intervention":742,"totalTrials":106,"cells":755},{"EARLY_PHASE1":756,"PHASE1":758,"PHASE2":760,"PHASE3":762,"PHASE4":764,"NA":770},{"trials":757,"activeCount":71},[],{"trials":759,"activeCount":71},[],{"trials":761,"activeCount":71},[],{"trials":763,"activeCount":71},[],{"trials":765,"activeCount":71},[766],{"nctId":729,"briefTitle":730,"status":320,"phases":767,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":768,"interventions":769},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":771,"activeCount":71},[],{"intervention":743,"totalTrials":106,"cells":773},{"EARLY_PHASE1":774,"PHASE1":776,"PHASE2":778,"PHASE3":780,"PHASE4":782,"NA":788},{"trials":775,"activeCount":71},[],{"trials":777,"activeCount":71},[],{"trials":779,"activeCount":71},[],{"trials":781,"activeCount":71},[],{"trials":783,"activeCount":71},[784],{"nctId":729,"briefTitle":730,"status":320,"phases":785,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":786,"interventions":787},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":789,"activeCount":71},[],{"intervention":744,"totalTrials":106,"cells":791},{"EARLY_PHASE1":792,"PHASE1":794,"PHASE2":796,"PHASE3":798,"PHASE4":800,"NA":806},{"trials":793,"activeCount":71},[],{"trials":795,"activeCount":71},[],{"trials":797,"activeCount":71},[],{"trials":799,"activeCount":71},[],{"trials":801,"activeCount":71},[802],{"nctId":729,"briefTitle":730,"status":320,"phases":803,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":804,"interventions":805},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":807,"activeCount":71},[],{"intervention":745,"totalTrials":106,"cells":809},{"EARLY_PHASE1":810,"PHASE1":812,"PHASE2":814,"PHASE3":816,"PHASE4":818,"NA":824},{"trials":811,"activeCount":71},[],{"trials":813,"activeCount":71},[],{"trials":815,"activeCount":71},[],{"trials":817,"activeCount":71},[],{"trials":819,"activeCount":71},[820],{"nctId":729,"briefTitle":730,"status":320,"phases":821,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":822,"interventions":823},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":825,"activeCount":71},[],{"intervention":746,"totalTrials":106,"cells":827},{"EARLY_PHASE1":828,"PHASE1":830,"PHASE2":832,"PHASE3":834,"PHASE4":836,"NA":842},{"trials":829,"activeCount":71},[],{"trials":831,"activeCount":71},[],{"trials":833,"activeCount":71},[],{"trials":835,"activeCount":71},[],{"trials":837,"activeCount":71},[838],{"nctId":729,"briefTitle":730,"status":320,"phases":839,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":840,"interventions":841},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":843,"activeCount":71},[],{"intervention":747,"totalTrials":106,"cells":845},{"EARLY_PHASE1":846,"PHASE1":848,"PHASE2":850,"PHASE3":852,"PHASE4":854,"NA":860},{"trials":847,"activeCount":71},[],{"trials":849,"activeCount":71},[],{"trials":851,"activeCount":71},[],{"trials":853,"activeCount":71},[],{"trials":855,"activeCount":71},[856],{"nctId":729,"briefTitle":730,"status":320,"phases":857,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":858,"interventions":859},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":861,"activeCount":71},[],{"intervention":748,"totalTrials":106,"cells":863},{"EARLY_PHASE1":864,"PHASE1":866,"PHASE2":868,"PHASE3":870,"PHASE4":872,"NA":878},{"trials":865,"activeCount":71},[],{"trials":867,"activeCount":71},[],{"trials":869,"activeCount":71},[],{"trials":871,"activeCount":71},[],{"trials":873,"activeCount":71},[874],{"nctId":729,"briefTitle":730,"status":320,"phases":875,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":876,"interventions":877},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":879,"activeCount":71},[],{"intervention":749,"totalTrials":106,"cells":881},{"EARLY_PHASE1":882,"PHASE1":884,"PHASE2":886,"PHASE3":888,"PHASE4":890,"NA":896},{"trials":883,"activeCount":71},[],{"trials":885,"activeCount":71},[],{"trials":887,"activeCount":71},[],{"trials":889,"activeCount":71},[],{"trials":891,"activeCount":71},[892],{"nctId":729,"briefTitle":730,"status":320,"phases":893,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":894,"interventions":895},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":897,"activeCount":71},[],{"intervention":750,"totalTrials":106,"cells":899},{"EARLY_PHASE1":900,"PHASE1":902,"PHASE2":904,"PHASE3":906,"PHASE4":908,"NA":914},{"trials":901,"activeCount":71},[],{"trials":903,"activeCount":71},[],{"trials":905,"activeCount":71},[],{"trials":907,"activeCount":71},[],{"trials":909,"activeCount":71},[910],{"nctId":729,"briefTitle":730,"status":320,"phases":911,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":912,"interventions":913},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":915,"activeCount":71},[],{"intervention":751,"totalTrials":106,"cells":917},{"EARLY_PHASE1":918,"PHASE1":920,"PHASE2":922,"PHASE3":924,"PHASE4":926,"NA":932},{"trials":919,"activeCount":71},[],{"trials":921,"activeCount":71},[],{"trials":923,"activeCount":71},[],{"trials":925,"activeCount":71},[],{"trials":927,"activeCount":71},[928],{"nctId":729,"briefTitle":730,"status":320,"phases":929,"primaryCompletion":732,"completion":733,"start":734,"enrollment":735,"conditions":930,"interventions":931},[63],[737,738,739,740],[716,742,743,744,745,746,747,748,749,750,751],{"trials":933,"activeCount":71},[],{"intervention":935,"totalTrials":106,"cells":936},"ramelteon",{"EARLY_PHASE1":937,"PHASE1":939,"PHASE2":941,"PHASE3":943,"PHASE4":945,"NA":957},{"trials":938,"activeCount":71},[],{"trials":940,"activeCount":71},[],{"trials":942,"activeCount":71},[],{"trials":944,"activeCount":71},[],{"trials":946,"activeCount":71},[947],{"nctId":948,"briefTitle":949,"status":83,"phases":950,"primaryCompletion":951,"completion":952,"start":953,"enrollment":366,"conditions":954,"interventions":956},"NCT02564939","Ramelteon Prevention of Delirium - RCT",[63],"2018-12","2019-06","2017-02-23",[955],"Delirium",[935],{"trials":958,"activeCount":71},[],{"intervention":960,"totalTrials":106,"cells":961},"Senna+ docusate",{"EARLY_PHASE1":962,"PHASE1":964,"PHASE2":966,"PHASE3":968,"PHASE4":979,"NA":981},{"trials":963,"activeCount":71},[],{"trials":965,"activeCount":71},[],{"trials":967,"activeCount":71},[],{"trials":969,"activeCount":71},[970],{"nctId":971,"briefTitle":972,"status":320,"phases":973,"primaryCompletion":974,"completion":974,"start":975,"enrollment":976,"conditions":977,"interventions":978},"NCT00571896","The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery",[61,62],"2009-06","2008-01",72,[739],[960],{"trials":980,"activeCount":71},[],{"trials":982,"activeCount":71},[],{"intervention":984,"totalTrials":106,"cells":985},"Sildenafil",{"EARLY_PHASE1":986,"PHASE1":988,"PHASE2":990,"PHASE3":992,"PHASE4":1003,"NA":1005},{"trials":987,"activeCount":71},[],{"trials":989,"activeCount":71},[],{"trials":991,"activeCount":71},[],{"trials":993,"activeCount":71},[994],{"nctId":995,"briefTitle":996,"status":83,"phases":997,"primaryCompletion":951,"completion":951,"start":998,"enrollment":470,"conditions":999,"interventions":1002},"NCT03460470","Sildenafil in US Heart Failure Patients (SilHF-US)",[62],"2018-02-14",[1000,1001],"Heart Failure","Pulmonary Hypertension",[984],{"trials":1004,"activeCount":71},[],{"trials":1006,"activeCount":71},[],{"intervention":1008,"totalTrials":106,"cells":1009},"Sugar Pill",{"EARLY_PHASE1":1010,"PHASE1":1012,"PHASE2":1014,"PHASE3":1027,"PHASE4":1029,"NA":1031},{"trials":1011,"activeCount":71},[],{"trials":1013,"activeCount":71},[],{"trials":1015,"activeCount":71},[1016],{"nctId":1017,"briefTitle":1018,"status":320,"phases":1019,"primaryCompletion":1020,"completion":1020,"start":975,"enrollment":1021,"conditions":1022,"interventions":1025},"NCT01361633","The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly",[61],"2009-02",51,[1023,1024],"Treatment","Placebo",[1026,1008],"d-cycloserine",{"trials":1028,"activeCount":71},[],{"trials":1030,"activeCount":71},[],{"trials":1032,"activeCount":71},[],{"intervention":1034,"totalTrials":106,"cells":1035},"Marijuana, Hash, THC, or Grass",{"EARLY_PHASE1":1036,"PHASE1":1038,"PHASE2":1040,"PHASE3":1053,"PHASE4":1055,"NA":1057},{"trials":1037,"activeCount":71},[],{"trials":1039,"activeCount":71},[],{"trials":1041,"activeCount":71},[1042],{"nctId":1043,"briefTitle":1044,"status":83,"phases":1045,"primaryCompletion":42,"completion":42,"start":1046,"enrollment":1047,"conditions":1048,"interventions":1052},"NCT05116527","THC Memory & Reward Learning Pilot",[60,61],"2022-07-07",20,[1049,1050,1051],"Marijuana","THC","Cannabis",[1034],{"trials":1054,"activeCount":71},[],{"trials":1056,"activeCount":71},[],{"trials":1058,"activeCount":71},[],{"intervention":1060,"totalTrials":106,"cells":1061},"Entereg",{"EARLY_PHASE1":1062,"PHASE1":1064,"PHASE2":1066,"PHASE3":1077,"PHASE4":1079,"NA":1081},{"trials":1063,"activeCount":71},[],{"trials":1065,"activeCount":71},[],{"trials":1067,"activeCount":71},[1068],{"nctId":1069,"briefTitle":1070,"status":320,"phases":1071,"primaryCompletion":732,"completion":732,"start":1072,"enrollment":1073,"conditions":1074,"interventions":1076},"NCT01258569","Entereg Laparoscopic Colon Resection Study",[61],"2010-11",135,[1075],"Laparoscopic Colonic Resection",[1060,1060],{"trials":1078,"activeCount":71},[],{"trials":1080,"activeCount":71},[],{"trials":1082,"activeCount":71},[],{"intervention":1084,"totalTrials":106,"cells":1085},"DFN-15",{"EARLY_PHASE1":1086,"PHASE1":1088,"PHASE2":1090,"PHASE3":1103,"PHASE4":1105,"NA":1107},{"trials":1087,"activeCount":71},[],{"trials":1089,"activeCount":71},[],{"trials":1091,"activeCount":71},[1092],{"nctId":1093,"briefTitle":1094,"status":320,"phases":1095,"primaryCompletion":1096,"completion":1096,"start":1097,"enrollment":1021,"conditions":1098,"interventions":1102},"NCT03472378","Can DFN-15 Terminate Migraine With Allodynia?",[61],"2019-04-12","2018-05-09",[1099,1100,1101],"Migraine With Aura","Migraine Without Aura","Allodynia",[1084],{"trials":1104,"activeCount":71},[],{"trials":1106,"activeCount":71},[],{"trials":1108,"activeCount":71},[],{"intervention":1110,"totalTrials":106,"cells":1111},"Celecoxib",{"EARLY_PHASE1":1112,"PHASE1":1114,"PHASE2":1116,"PHASE3":1129,"PHASE4":1131,"NA":1133},{"trials":1113,"activeCount":71},[],{"trials":1115,"activeCount":71},[],{"trials":1117,"activeCount":71},[1118],{"nctId":1119,"briefTitle":1120,"status":320,"phases":1121,"primaryCompletion":1122,"completion":1122,"start":1123,"enrollment":1124,"conditions":1125,"interventions":1127},"NCT01425476","Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors",[60,61],"2016-11","2008-07",45,[1126],"Breast Cancer",[1110,1128],"Cholecalciferol",{"trials":1130,"activeCount":71},[],{"trials":1132,"activeCount":71},[],{"trials":1134,"activeCount":71},[],{"intervention":1128,"totalTrials":106,"cells":1136},{"EARLY_PHASE1":1137,"PHASE1":1139,"PHASE2":1141,"PHASE3":1147,"PHASE4":1149,"NA":1151},{"trials":1138,"activeCount":71},[],{"trials":1140,"activeCount":71},[],{"trials":1142,"activeCount":71},[1143],{"nctId":1119,"briefTitle":1120,"status":320,"phases":1144,"primaryCompletion":1122,"completion":1122,"start":1123,"enrollment":1124,"conditions":1145,"interventions":1146},[60,61],[1126],[1110,1128],{"trials":1148,"activeCount":71},[],{"trials":1150,"activeCount":71},[],{"trials":1152,"activeCount":71},[],{"intervention":1154,"totalTrials":106,"cells":1155},"CBD",{"EARLY_PHASE1":1156,"PHASE1":1158,"PHASE2":1160,"PHASE3":1170,"PHASE4":1172,"NA":1174},{"trials":1157,"activeCount":71},[],{"trials":1159,"activeCount":71},[],{"trials":1161,"activeCount":71},[1162],{"nctId":1163,"briefTitle":1164,"status":83,"phases":1165,"primaryCompletion":1166,"completion":1166,"start":1167,"enrollment":1047,"conditions":1168,"interventions":1169},"NCT04778644","Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task",[60,61],"2025-12-15","2021-12-15",[1154],[1154],{"trials":1171,"activeCount":71},[],{"trials":1173,"activeCount":71},[],{"trials":1175,"activeCount":71},[],{"intervention":1177,"totalTrials":106,"cells":1178},"Low Dose Beta-Caryophyllene",{"EARLY_PHASE1":1179,"PHASE1":1181,"PHASE2":1183,"PHASE3":1197,"PHASE4":1199,"NA":1201},{"trials":1180,"activeCount":71},[],{"trials":1182,"activeCount":71},[],{"trials":1184,"activeCount":71},[1185],{"nctId":1186,"briefTitle":1187,"status":1188,"phases":1189,"primaryCompletion":1190,"completion":1190,"start":1191,"enrollment":71,"conditions":1192,"interventions":1194},"NCT04794205","Acute Changes In Thermal Pain Response Following Single Oral Dose of Beta-Cary","WITHDRAWN",[60,61],"2022-04","2021-09",[1193],"Beta-Caryophyllene",[1177,1195,1196],"Medium Dose Beta-Caryophyllene","High Dose Beta-Caryophyllene",{"trials":1198,"activeCount":71},[],{"trials":1200,"activeCount":71},[],{"trials":1202,"activeCount":71},[],{"intervention":1195,"totalTrials":106,"cells":1204},{"EARLY_PHASE1":1205,"PHASE1":1207,"PHASE2":1209,"PHASE3":1215,"PHASE4":1217,"NA":1219},{"trials":1206,"activeCount":71},[],{"trials":1208,"activeCount":71},[],{"trials":1210,"activeCount":71},[1211],{"nctId":1186,"briefTitle":1187,"status":1188,"phases":1212,"primaryCompletion":1190,"completion":1190,"start":1191,"enrollment":71,"conditions":1213,"interventions":1214},[60,61],[1193],[1177,1195,1196],{"trials":1216,"activeCount":71},[],{"trials":1218,"activeCount":71},[],{"trials":1220,"activeCount":71},[],{"intervention":1196,"totalTrials":106,"cells":1222},{"EARLY_PHASE1":1223,"PHASE1":1225,"PHASE2":1227,"PHASE3":1233,"PHASE4":1235,"NA":1237},{"trials":1224,"activeCount":71},[],{"trials":1226,"activeCount":71},[],{"trials":1228,"activeCount":71},[1229],{"nctId":1186,"briefTitle":1187,"status":1188,"phases":1230,"primaryCompletion":1190,"completion":1190,"start":1191,"enrollment":71,"conditions":1231,"interventions":1232},[60,61],[1193],[1177,1195,1196],{"trials":1234,"activeCount":71},[],{"trials":1236,"activeCount":71},[],{"trials":1238,"activeCount":71},[],{"intervention":1240,"totalTrials":106,"cells":1241},"Tebipenem tablet form",{"EARLY_PHASE1":1242,"PHASE1":1244,"PHASE2":1255,"PHASE3":1257,"PHASE4":1259,"NA":1261},{"trials":1243,"activeCount":71},[],{"trials":1245,"activeCount":71},[1246],{"nctId":1247,"briefTitle":1248,"status":320,"phases":1249,"primaryCompletion":339,"completion":1250,"start":1251,"enrollment":445,"conditions":1252,"interventions":1254},"NCT05296382","Bioavailability of Tebipenem (SPR994) Crushed Tablet",[60],"2022-12-23","2022-04-01",[1253],"Relative Bioavailability",[1240],{"trials":1256,"activeCount":71},[],{"trials":1258,"activeCount":71},[],{"trials":1260,"activeCount":71},[],{"trials":1262,"activeCount":71},[],{"intervention":1264,"totalTrials":106,"cells":1265},"Ceftolozane\u002Ftazobactam",{"EARLY_PHASE1":1266,"PHASE1":1268,"PHASE2":1279,"PHASE3":1281,"PHASE4":1283,"NA":1285},{"trials":1267,"activeCount":71},[],{"trials":1269,"activeCount":71},[1270],{"nctId":1271,"briefTitle":1272,"status":320,"phases":1273,"primaryCompletion":1274,"completion":1274,"start":1275,"enrollment":1276,"conditions":1277,"interventions":1278},"NCT02620774","Tissue Penetration of Ceftolozane\u002FTazobactam in Diabetic Patients With Lower Limb Infections",[60],"2017-04","2016-02-19",16,[23,25,28],[1264],{"trials":1280,"activeCount":71},[],{"trials":1282,"activeCount":71},[],{"trials":1284,"activeCount":71},[],{"trials":1286,"activeCount":71},[],{"intervention":1288,"totalTrials":106,"cells":1289},"Rezafungin",{"EARLY_PHASE1":1290,"PHASE1":1292,"PHASE2":1302,"PHASE3":1304,"PHASE4":1306,"NA":1308},{"trials":1291,"activeCount":71},[],{"trials":1293,"activeCount":71},[1294],{"nctId":1295,"briefTitle":1296,"status":1188,"phases":1297,"primaryCompletion":338,"completion":338,"start":1298,"enrollment":71,"conditions":1299,"interventions":1301},"NCT06329518","Rezafungin Pharmacokinetics in Patients on ECMO",[60],"2024-07-01",[1300],"Sepsis",[1288],{"trials":1303,"activeCount":71},[],{"trials":1305,"activeCount":71},[],{"trials":1307,"activeCount":71},[],{"trials":1309,"activeCount":71},[],{"intervention":1311,"totalTrials":106,"cells":1312},"Imipenem-relebactam",{"EARLY_PHASE1":1313,"PHASE1":1315,"PHASE2":1326,"PHASE3":1328,"PHASE4":1330,"NA":1332},{"trials":1314,"activeCount":71},[],{"trials":1316,"activeCount":71},[1317],{"nctId":1318,"briefTitle":1319,"status":320,"phases":1320,"primaryCompletion":1321,"completion":1322,"start":1323,"enrollment":256,"conditions":1324,"interventions":1325},"NCT04147221","Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance",[60],"2021-09-10","2021-09-19","2020-02-10",[1300],[1311],{"trials":1327,"activeCount":71},[],{"trials":1329,"activeCount":71},[],{"trials":1331,"activeCount":71},[],{"trials":1333,"activeCount":71},[],{"intervention":1335,"totalTrials":106,"cells":1336},"Omadacycline",{"EARLY_PHASE1":1337,"PHASE1":1339,"PHASE2":1349,"PHASE3":1351,"PHASE4":1353,"NA":1355},{"trials":1338,"activeCount":71},[],{"trials":1340,"activeCount":71},[1341],{"nctId":1342,"briefTitle":1343,"status":320,"phases":1344,"primaryCompletion":1345,"completion":1346,"start":1323,"enrollment":97,"conditions":1347,"interventions":1348},"NCT04144374","Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis",[60],"2021-07-12","2021-07-29",[23,25,28],[1335],{"trials":1350,"activeCount":71},[],{"trials":1352,"activeCount":71},[],{"trials":1354,"activeCount":71},[],{"trials":1356,"activeCount":71},[],{"intervention":1358,"totalTrials":106,"cells":1359},"Tebipenem Pivoxil Hydrobromide",{"EARLY_PHASE1":1360,"PHASE1":1362,"PHASE2":1373,"PHASE3":1375,"PHASE4":1377,"NA":1379},{"trials":1361,"activeCount":71},[],{"trials":1363,"activeCount":71},[1364],{"nctId":1365,"briefTitle":1366,"status":320,"phases":1367,"primaryCompletion":1368,"completion":1250,"start":1369,"enrollment":445,"conditions":1370,"interventions":1372},"NCT04919954","Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis",[60],"2022-08-30","2021-07-01",[23,25,1371,28],"ABSSSI",[1358],{"trials":1374,"activeCount":71},[],{"trials":1376,"activeCount":71},[],{"trials":1378,"activeCount":71},[],{"trials":1380,"activeCount":71},[],{"intervention":1382,"totalTrials":106,"cells":1383},"Tedizolid",{"EARLY_PHASE1":1384,"PHASE1":1386,"PHASE2":1397,"PHASE3":1399,"PHASE4":1401,"NA":1403},{"trials":1385,"activeCount":71},[],{"trials":1387,"activeCount":71},[1388],{"nctId":1389,"briefTitle":1390,"status":320,"phases":1391,"primaryCompletion":1392,"completion":1392,"start":1393,"enrollment":1394,"conditions":1395,"interventions":1396},"NCT02620787","Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis",[60],"2017-03-01","2016-02-23",18,[23,25,28],[1382],{"trials":1398,"activeCount":71},[],{"trials":1400,"activeCount":71},[],{"trials":1402,"activeCount":71},[],{"trials":1404,"activeCount":71},[],{"intervention":1406,"totalTrials":106,"cells":1407},"Cannabidiol Cap\u002FTab",{"EARLY_PHASE1":1408,"PHASE1":1419,"PHASE2":1421,"PHASE3":1423,"PHASE4":1425,"NA":1427},{"trials":1409,"activeCount":71},[1410],{"nctId":1411,"briefTitle":1412,"status":83,"phases":1413,"primaryCompletion":1414,"completion":1414,"start":1415,"enrollment":1047,"conditions":1416,"interventions":1418},"NCT06123702","Cannabidiol Effects on Fear Extinction in Social Phobia",[59],"2024-12-31","2024-04-30",[1417],"Social Anxiety Disorder",[1406],{"trials":1420,"activeCount":71},[],{"trials":1422,"activeCount":71},[],{"trials":1424,"activeCount":71},[],{"trials":1426,"activeCount":71},[],{"trials":1428,"activeCount":71},[],{"intervention":1430,"totalTrials":9,"cells":1431},"D-cycloserine",{"EARLY_PHASE1":1432,"PHASE1":1434,"PHASE2":1436,"PHASE3":1442,"PHASE4":1444,"NA":1446},{"trials":1433,"activeCount":71},[],{"trials":1435,"activeCount":71},[],{"trials":1437,"activeCount":71},[1438],{"nctId":1017,"briefTitle":1018,"status":320,"phases":1439,"primaryCompletion":1020,"completion":1020,"start":975,"enrollment":1021,"conditions":1440,"interventions":1441},[61],[1023,1024],[1026,1008],{"trials":1443,"activeCount":71},[],{"trials":1445,"activeCount":71},[],{"trials":1447,"activeCount":71},[1448,1456],{"nctId":1449,"briefTitle":1450,"status":320,"phases":1451,"primaryCompletion":1452,"completion":1452,"start":638,"enrollment":1047,"conditions":1453,"interventions":1455},"NCT01450306","Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics",[64],"2011-12",[1454],"Specific Phobia",[1430],{"nctId":1457,"briefTitle":1458,"status":320,"phases":1459,"completion":1460,"start":1461,"enrollment":497,"conditions":1462,"interventions":1464},"NCT00131339","Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder",[64],"2007-03","2004-11",[1463],"Panic Disorder",[1430],{"intervention":1466,"totalTrials":106,"cells":1467},"Atorvastatin",{"EARLY_PHASE1":1468,"PHASE1":1470,"PHASE2":1472,"PHASE3":1474,"PHASE4":1476,"NA":1478},{"trials":1469,"activeCount":71},[],{"trials":1471,"activeCount":71},[],{"trials":1473,"activeCount":71},[],{"trials":1475,"activeCount":71},[],{"trials":1477,"activeCount":71},[],{"trials":1479,"activeCount":71},[1480],{"nctId":1481,"briefTitle":1482,"status":320,"phases":1483,"primaryCompletion":1484,"completion":1484,"start":975,"enrollment":1485,"conditions":1486,"interventions":1489},"NCT00609063","The Effect of Statin Medications on Muscle Performance (The STOMP Study)",[64],"2011-06",420,[1487,1488],"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Muscular Diseases",[1466],{"intervention":1491,"totalTrials":106,"cells":1492},"CoEnzyme Q10",{"EARLY_PHASE1":1493,"PHASE1":1495,"PHASE2":1497,"PHASE3":1499,"PHASE4":1501,"NA":1503},{"trials":1494,"activeCount":71},[],{"trials":1496,"activeCount":71},[],{"trials":1498,"activeCount":71},[],{"trials":1500,"activeCount":71},[],{"trials":1502,"activeCount":71},[],{"trials":1504,"activeCount":71},[1505],{"nctId":1506,"briefTitle":1507,"status":83,"phases":1508,"primaryCompletion":1509,"completion":1509,"start":1510,"enrollment":1073,"conditions":1511,"interventions":1513},"NCT01140308","CoEnzyme Q10 in Statin Myopathy",[64],"2013-09","2009-09",[1512],"Statin Myopathy",[1491],{"intervention":1515,"totalTrials":106,"cells":1516},"Amiodarone Plus Ranolazine",{"EARLY_PHASE1":1517,"PHASE1":1519,"PHASE2":1521,"PHASE3":1523,"PHASE4":1525,"NA":1527},{"trials":1518,"activeCount":71},[],{"trials":1520,"activeCount":71},[],{"trials":1522,"activeCount":71},[],{"trials":1524,"activeCount":71},[],{"trials":1526,"activeCount":71},[],{"trials":1528,"activeCount":71},[1529],{"nctId":1530,"briefTitle":1531,"status":320,"phases":1532,"primaryCompletion":1533,"completion":1533,"start":1534,"enrollment":1535,"conditions":1536,"interventions":1537},"NCT01480336","The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot",[64],"2013-01","2011-02",19,[376],[1515,1538],"Amiodarone with Placebo",{"intervention":1538,"totalTrials":106,"cells":1540},{"EARLY_PHASE1":1541,"PHASE1":1543,"PHASE2":1545,"PHASE3":1547,"PHASE4":1549,"NA":1551},{"trials":1542,"activeCount":71},[],{"trials":1544,"activeCount":71},[],{"trials":1546,"activeCount":71},[],{"trials":1548,"activeCount":71},[],{"trials":1550,"activeCount":71},[],{"trials":1552,"activeCount":71},[1553],{"nctId":1530,"briefTitle":1531,"status":320,"phases":1554,"primaryCompletion":1533,"completion":1533,"start":1534,"enrollment":1535,"conditions":1555,"interventions":1556},[64],[376],[1515,1538],{"intervention":1558,"totalTrials":106,"cells":1559},"Bupivacaine liposomal",{"EARLY_PHASE1":1560,"PHASE1":1562,"PHASE2":1564,"PHASE3":1566,"PHASE4":1568,"NA":1570},{"trials":1561,"activeCount":71},[],{"trials":1563,"activeCount":71},[],{"trials":1565,"activeCount":71},[],{"trials":1567,"activeCount":71},[],{"trials":1569,"activeCount":71},[],{"trials":1571,"activeCount":71},[1572],{"nctId":1573,"briefTitle":1574,"status":83,"phases":1575,"primaryCompletion":1576,"completion":1577,"start":1578,"enrollment":1579,"conditions":1580,"interventions":1581},"NCT02890199","Effect of Local Anesthesia on Postoperative Pain Following Sacrospinous Ligament Fixation",[64],"2017-06","2017-07","2016-10",30,[18],[1558,1582],"Lidocaine",{"intervention":1582,"totalTrials":106,"cells":1584},{"EARLY_PHASE1":1585,"PHASE1":1587,"PHASE2":1589,"PHASE3":1591,"PHASE4":1593,"NA":1595},{"trials":1586,"activeCount":71},[],{"trials":1588,"activeCount":71},[],{"trials":1590,"activeCount":71},[],{"trials":1592,"activeCount":71},[],{"trials":1594,"activeCount":71},[],{"trials":1596,"activeCount":71},[1597],{"nctId":1573,"briefTitle":1574,"status":83,"phases":1598,"primaryCompletion":1576,"completion":1577,"start":1578,"enrollment":1579,"conditions":1599,"interventions":1600},[64],[18],[1558,1582],{"intervention":1602,"totalTrials":106,"cells":1603},"Phenazopyridine",{"EARLY_PHASE1":1604,"PHASE1":1606,"PHASE2":1608,"PHASE3":1610,"PHASE4":1612,"NA":1614},{"trials":1605,"activeCount":71},[],{"trials":1607,"activeCount":71},[],{"trials":1609,"activeCount":71},[],{"trials":1611,"activeCount":71},[],{"trials":1613,"activeCount":71},[],{"trials":1615,"activeCount":71},[1616],{"nctId":1617,"briefTitle":1618,"status":320,"phases":1619,"primaryCompletion":1620,"completion":1620,"start":1621,"enrollment":1622,"conditions":1623,"interventions":1625},"NCT02424149","Phenazopyridine for Confirmation of Ureteral Patency",[64],"2016-01","2015-04",107,[1624],"Cystoscopy",[1602],{"intervention":1627,"totalTrials":106,"cells":1628},"Estradiol",{"EARLY_PHASE1":1629,"PHASE1":1631,"PHASE2":1633,"PHASE3":1635,"PHASE4":1637,"NA":1639},{"trials":1630,"activeCount":71},[],{"trials":1632,"activeCount":71},[],{"trials":1634,"activeCount":71},[],{"trials":1636,"activeCount":71},[],{"trials":1638,"activeCount":71},[],{"trials":1640,"activeCount":71},[1641],{"nctId":1642,"briefTitle":1643,"status":83,"phases":1644,"completion":1645,"start":1646,"enrollment":1647,"conditions":1648,"interventions":1651},"NCT00547001","Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes",[64],"2009-11","2007-08",235,[1649,1650],"Hot Flashes","Night Sweats",[1627],{"intervention":1653,"totalTrials":106,"cells":1654},"Nicotrol Inhaler",{"EARLY_PHASE1":1655,"PHASE1":1657,"PHASE2":1659,"PHASE3":1661,"PHASE4":1663,"NA":1665},{"trials":1656,"activeCount":71},[],{"trials":1658,"activeCount":71},[],{"trials":1660,"activeCount":71},[],{"trials":1662,"activeCount":71},[],{"trials":1664,"activeCount":71},[],{"trials":1666,"activeCount":71},[1667],{"nctId":1668,"briefTitle":1669,"status":320,"phases":1670,"primaryCompletion":1671,"completion":1672,"start":1673,"enrollment":340,"conditions":1674,"interventions":1676},"NCT00888979","Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy",[64],"2011-05","2014-04","2009-04",[1675],"Tobacco Use Disorder",[1653],{"intervention":1678,"totalTrials":106,"cells":1679},"Regadenoson",{"EARLY_PHASE1":1680,"PHASE1":1682,"PHASE2":1684,"PHASE3":1686,"PHASE4":1688,"NA":1690},{"trials":1681,"activeCount":71},[],{"trials":1683,"activeCount":71},[],{"trials":1685,"activeCount":71},[],{"trials":1687,"activeCount":71},[],{"trials":1689,"activeCount":71},[],{"trials":1691,"activeCount":71},[1692],{"nctId":1693,"briefTitle":1694,"status":320,"phases":1695,"primaryCompletion":1696,"completion":1696,"start":1697,"enrollment":1698,"conditions":1699,"interventions":1700},"NCT01021618","Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging",[64],"2012-03","2010-01",140,[21,30],[1678],{"intervention":1702,"totalTrials":106,"cells":1703},"One day with a dose of placebo cannabis paired with alcohol",{"EARLY_PHASE1":1704,"PHASE1":1706,"PHASE2":1708,"PHASE3":1710,"PHASE4":1712,"NA":1714},{"trials":1705,"activeCount":71},[],{"trials":1707,"activeCount":71},[],{"trials":1709,"activeCount":71},[],{"trials":1711,"activeCount":71},[],{"trials":1713,"activeCount":71},[],{"trials":1715,"activeCount":71},[1716],{"nctId":1717,"briefTitle":1718,"status":83,"phases":1719,"primaryCompletion":86,"completion":86,"start":1720,"enrollment":8,"conditions":1721,"interventions":1724},"NCT03431987","Neuroscience of Alcohol and Marijuana Impaired Driving",[],"2018-07-01",[1722,1723],"Marijuana Usage","Alcohol Drinking",[1702,1725],"One day with a dose of active THC cannabis paired with alcohol",{"intervention":1725,"totalTrials":106,"cells":1727},{"EARLY_PHASE1":1728,"PHASE1":1730,"PHASE2":1732,"PHASE3":1734,"PHASE4":1736,"NA":1738},{"trials":1729,"activeCount":71},[],{"trials":1731,"activeCount":71},[],{"trials":1733,"activeCount":71},[],{"trials":1735,"activeCount":71},[],{"trials":1737,"activeCount":71},[],{"trials":1739,"activeCount":71},[1740],{"nctId":1717,"briefTitle":1718,"status":83,"phases":1741,"primaryCompletion":86,"completion":86,"start":1720,"enrollment":8,"conditions":1742,"interventions":1743},[],[1722,1723],[1702,1725]]